Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents
GlobeNewswire
Policy change comes quickly after FDA clearance for NeuroStar TMS use in ages 15 and older
MALVERN, Pa., May 15, 2024..
Transcranial magnetic stimulation
News and Video Search Results
News coverage
-
BrainsWay Reports First Quarter 2024 Financial Results and Operational Highlights
GlobeNewswire
-
Finnish Hospital Orders Nexstim NBS System 5
GlobeNewswire
-
Health Canada Approves Nexstim NBS 6 System for Treatment of MDD
GlobeNewswire
-
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
0 shares
1 views
You might like
Transcranial magnetic stimulation media coverage
Nexstim, Inc. and Inomed Inc. Enter into Strategic Alliance Agreement for US Market
GlobeNewswire
Press release, Helsinki, 3 May 2024, 10 AM (EEST)*Nexstim, Inc. and Inomed Inc. Enter into Strategic Alliance Agreement for US..
-
NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness Month
GlobeNewswire
-
Compass Pathways and Journey Clinical establish research collaboration agreement to inform the training of healthcare providers and delivery model for COMP360 psilocybin treatment, if approved for treatment-resistant depression
GlobeNewswire
-
Neurosurgery Customer from Germany Orders Nexstim NBS System 5
GlobeNewswire
-
Nexstim Plc Business Update Q1 2024
GlobeNewswire
Advertisement
More coverage
Nexstim Plc: Managers’ Transactions, Hildén
GlobeNewswire
Company Announcement, Helsinki, 25 April 2024 at 1:15 PM (EEST)*Nexstim Plc: Managers’ Transactions, Hildén*
Nexstim..
-
Nexstim Plc: Managers’ Transactions, Forss
GlobeNewswire
-
Nexstim Plc: Managers’ Transactions, Weckroth
GlobeNewswire
-
Nexstim Plc: Managers’ Transactions, Niemistö
GlobeNewswire
-
Nexstim Receives NBS 6 System Order from Clinic in Florida, US
GlobeNewswire